Oncology
Showing 51 to 100 of 294 entries
| Category | Product Name | ABC # | Size | NDC # | Manufacturer | |
|---|---|---|---|---|---|---|
| Oncology | Decitabine | 10123966 | 50 mg SDV | 55111-0556-10 | Dr Reddys Lab | |
| Oncology | Dysport® | 10244421 | 300 units/vl | 15054-0530-06 | Ipsen Pharmaceuticals | |
| Oncology | Elahere™ | 10274316 | 100 mg/20 mL SDV | 72903-0853-01 | ImmunoGen | |
| Oncology | Elzonris® | 10251193 | 1000 mcg/mL | 72187-0401-01 | Stemline Therapeutics | |
| Oncology | Empliciti® | 10247509 | 300 mg SDV LYO | 00003-2291-11 | Bristol Myers Squibb | |
| Oncology | Empliciti® | 10246869 | 400 mg SDV LYO | 00003-4522-11 | Bristol Myers Squibb | |
| Oncology | Enhertu® | 10248180 | 100 mg SDV | 65597-0406-01 | Daiichi Sankyo Inc. | |
| Oncology | Erbitux® | 10249300 | 100 mg/50 mL | 66733-0948-23 | Eli Lilly & Co | |
| Oncology | Erbitux® | 10248127 | 200 mg/100 mL | 66733-0958-23 | Eli Lilly & Co | |
| Oncology | Erivedge® | 10249001 | 150 mg/28 caps | 50242-0140-01 | Genentech | |
| Oncology | Erleada® | 10246427 | 60 mg tab 120 | 59676-0600-12 | Jom Pharmaceutical | |
| Oncology | Exkivity™ | 10261629 | 40 mg/120 caps | 63020-040-12 | Takeda | |
| Oncology | Farydak® | 10245608 | 15 mg cap 6 UD | 00078-0651-06 | Secura Bio | |
| Oncology | Farydak® | 10245902 | 10 mg cap 6 UD | 00078-0650-06 | Secura Bio | |
| Oncology | Farydak® | 10245153 | 20 mg cap 6 UD | 00078-0652-06 | Secura Bio | |
| Oncology | Faslodex® | 10244609 | 500 mg PFS 2 × 5.0 mL | 00310-0720-10 | AstraZeneca | |
| Oncology | Folotyn™ | 10254579 | 20 mg | 48818-0001-01 | Aurobindo/Acrotech Biopharma | |
| Oncology | Folotyn™ | 10254519 | 40 mg | 48818-0001-02 | Aurobindo/Acrotech Biopharma | |
| Oncology | Fotivda® | 10255521 | 1.34 mg/21 caps | 45629-0134-01 | Aveo Oncology | |
| Oncology | Fotivda® | 10255520 | 0.89 mg/21 caps | 45629-0089-01 | Aveo Oncology | |
| Oncology | Gazyva® | 10247265 | 1000 mg/40 mL | 50242-0070-01 | Genentech | |
| Oncology | Gilotrif® | 10248897 | 40 mg/30 tabs | 00597-0138-30 | Boehringer Ingelheim | |
| Oncology | Gilotrif® | 10248915 | 20 mg/30 tabs | 00597-0141-30 | Boehringer Ingelheim | |
| Oncology | Gilotrif® | 10248982 | 30 mg/30 tabs | 00597-0137-30 | Boehringer Ingelheim | |
| Oncology | Halaven® | 10245260 | 1 mg/2 mL SDV | 62856-0389-01 | Eisai | |
| NEW | Oncology | Hemady® | 10254602 | 20 mg/24 tabs | 72893-0015-24 | Acrotech Biopharma |
| NEW | Oncology | Hemady® | 10254594 | 20 mg/100 tabs | 72893-0015-06 | Acrotech Biopharma |
| Oncology | Herceptin Hylecta™ | 10247908 | 600 mg SDV | 50242-0077-01 | Genentech | |
| Oncology | Herceptin® | 10245092 | 150 mg SDV | 50242-0132-01 | Genentech | |
| Oncology | Ibrance® | 10246008 | 75 mg/21 caps | 00069-0187-21 | Pfizer | |
| Oncology | Ibrance® | 10248309 | 125 mg/21 caps | 00069-0189-21 | Pfizer | |
| Oncology | Ibrance® | 10246977 | 100 mg/21 caps | 00069-0188-21 | Pfizer | |
| Oncology | IDHIFA® | 10258528 | 100 mg/30 tabs | 59572-0710-30 | Celgene Corporation | |
| Oncology | IDHIFA® | 10258527 | 50 mg/30 tabs | 59572-0705-30 | Celgene Corporation | |
| Oncology | Imbruvica® | 10247477 | 280 mg tab 28 UD | 57962-0280-28 | Pharmacyclics | |
| Oncology | Imbruvica® | 10245932 | 140 mg/120 caps | 57962-0140-12 | Pharmacyclics | |
| Oncology | Imbruvica® | 10249013 | 140 mg/90 caps | 57962-0140-09 | Pharmacyclics | |
| Oncology | Imbruvica® | 10248944 | 560 mg tab 28 UD | 57962-0560-28 | Pharmacyclics | |
| Oncology | Imbruvica® | 10245946 | 70 mg/28 caps | 57962-0070-28 | Pharmacyclics | |
| Oncology | Imbruvica® | 10244383 | 140 mg tab 28 UD | 57962-0014-28 | Pharmacyclics | |
| Oncology | Imbruvica® | 10245958 | 420 mg tab 28 UD | 57962-0420-28 | Pharmacyclics | |
| Oncology | Imfinzi® | 10246558 | 500 mg SDV | 00310-4611-50 | AstraZeneca | |
| Oncology | Imfinzi® | 10248457 | 120 mg SDV | 00310-4500-12 | AstraZeneca | |
| Oncology | Imjudo® | 10274570 | 25 mg/1.25 mL SDV | 00310-4505-25 | AstraZeneca | |
| Oncology | Imjudo® | 10274571 | 300 mg/15 mL SDV | 00310-4535-30 | AstraZeneca | |
| Oncology | Imlygic® | 10251066 | 106 1 m PFU/mL 1 mL vl | 55513-0078-01 | Amgen | |
| Oncology | Imlygic® | 10250987 | 108 100 m PFU/mL 1 mL vl | 55513-0079-01 | Amgen | |
| Oncology | Inlyta® | 10249008 | 1 mg tab 180 | 00069-0145-01 | Pfizer | |
| Oncology | Inlyta® | 10244389 | 5 mg tab 60 | 00069-0151-11 | Pfizer | |
| Oncology | Inrebic® | 10258496 | 100 mg/120 caps | 59572-0720-12 | Celgene Corporation |